USPTO serial 79237909
GENEVANT
Reviewed by CopyMark Law Group
Reg. 5946662Status 708Registered
- Filing date
- Status date
- Registration date
- Dec 31, 2019
- Examiner
- LEE, DOUGLAS
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with GENEVANT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joyce M. Ferraro
Joyce M. Ferraro Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical preparations for human use to treat genetic diseases and disorders and diseases and disorders associated with insufficient or faulty protein production or overproduction; biological preparations for medical or therapeutic use to treat genetic diseases and disorders and diseases and disorders associated with insufficient or faulty protein production or overproduction ] | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services as well as research and design services relating thereto, namely, scientific research and development and product research and development; biomedical and pharmaceutical research services; research in the field of therapeutic biological and pharmaceutical preparations; pharmaceutical research and development; providing information relating to scientific research in the field of pharmaceutical and biomedicine | ACTIVE | — |
| 044 | Provision of health information and medical information; provision of information concerning the [ diagnostic, prophylactic and ] therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseases, disorders and pathologies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genevant Sciences GmbH
- Other trademarks owned by Genevant Sciences GmbH
- Other trademarks owned by Genevant Sciences GmbH
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GENEVANT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 11, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Sep 11, 2026 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Sep 7, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 16, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Dec 31, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 11, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 8, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 16, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 16, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 31, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 31, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 15, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 15, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 12, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 25, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 25, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 25, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 12, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 11, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 9, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 9, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 9, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 9, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 9, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 9, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 9, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 5, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 4, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 4, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 7, 2018 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Dec 7, 2018 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Nov 23, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Oct 19, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Oct 11, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 4, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 4, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 30, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 18, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 17, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 13, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 7, 2018 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 2, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |